KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Other financing activities (2020 - 2023)

GoodRx Holdings' Other financing activities history spans 4 years, with the latest figure at $3.7 million for Q1 2023.

  • On a quarterly basis, Other financing activities fell 61.2% to $3.7 million in Q1 2023 year-over-year; TTM through Dec 2025 was $3.7 million, a 126.79% increase, with the full-year FY2024 number at $2.7 million, changed N/A from a year prior.
  • Other financing activities hit $3.7 million in Q1 2023 for GoodRx Holdings, up from -$17.6 million in the prior quarter.
  • Over the last five years, Other financing activities for GDRX hit a ceiling of $81.7 million in Q4 2020 and a floor of -$17.6 million in Q4 2022.
  • Historically, Other financing activities has averaged $13.1 million across 4 years, with a median of $7.1 million in 2022.
  • Biggest five-year swings in Other financing activities: surged 493.62% in 2021 and later tumbled 80.37% in 2022.
  • Tracing GDRX's Other financing activities over 4 years: stood at $81.7 million in 2020, then crashed by 79.62% to $16.7 million in 2021, then tumbled by 205.4% to -$17.6 million in 2022, then surged by 121.13% to $3.7 million in 2023.
  • Business Quant data shows Other financing activities for GDRX at $3.7 million in Q1 2023, -$17.6 million in Q4 2022, and $3.3 million in Q3 2022.